Nick talks to Dr. Berra Yazar-Klosinski, the Chief Science Officer for the Multidisciplinary Association for Psychedelic Studies (MAPS). Berra talked about the results of MAPS' recent Phase III clinical trials for treating severe PTSD, how these studies are conducted, and what we know about the underlying biology of Post-Traumatic Stress Disorder (PTSD) and the drug MDMA.
Click here to download audio, watch video, or read show notes & transcripts.
See this content to learn more about psychedelic science.
If you enjoy my content and want to further support M&M, please read this.
MDMA ("Ecstasy"), PTSD, Psychotherapy & MAPS | Berra Yazar-Klosinski | #26